 Benedetto Mungo
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophagectomy | 13 | 2023 | 110 | 2.100 |
Why?
| | Esophageal Neoplasms | 11 | 2023 | 281 | 1.870 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 89 | 1.270 |
Why?
| | Thoracic Surgery, Video-Assisted | 3 | 2016 | 41 | 1.190 |
Why?
| | Pancreatic Neoplasms | 3 | 2022 | 734 | 1.100 |
Why?
| | Laparoscopy | 5 | 2017 | 417 | 0.970 |
Why?
| | Postoperative Complications | 13 | 2023 | 2235 | 0.890 |
Why?
| | Hernia, Hiatal | 4 | 2017 | 34 | 0.670 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 210 | 0.660 |
Why?
| | Herniorrhaphy | 3 | 2014 | 52 | 0.630 |
Why?
| | Pneumonectomy | 2 | 2016 | 115 | 0.600 |
Why?
| | Colectomy | 1 | 2017 | 84 | 0.580 |
Why?
| | Anastomosis, Surgical | 3 | 2015 | 146 | 0.560 |
Why?
| | Lymph Node Excision | 2 | 2016 | 158 | 0.550 |
Why?
| | Neoadjuvant Therapy | 3 | 2015 | 333 | 0.550 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2023 | 158 | 0.540 |
Why?
| | Adenocarcinoma | 3 | 2016 | 812 | 0.530 |
Why?
| | Colonic Neoplasms | 1 | 2017 | 224 | 0.520 |
Why?
| | Retrospective Studies | 23 | 2023 | 12978 | 0.510 |
Why?
| | Length of Stay | 10 | 2017 | 1032 | 0.510 |
Why?
| | Lung Neoplasms | 2 | 2016 | 2220 | 0.430 |
Why?
| | Databases, Factual | 7 | 2017 | 1231 | 0.370 |
Why?
| | Treatment Outcome | 16 | 2023 | 9342 | 0.370 |
Why?
| | Aged | 21 | 2017 | 19657 | 0.360 |
Why?
| | Operative Time | 4 | 2015 | 114 | 0.310 |
Why?
| | Esophageal Diseases | 2 | 2017 | 26 | 0.290 |
Why?
| | Middle Aged | 18 | 2017 | 27617 | 0.290 |
Why?
| | Patient Readmission | 3 | 2017 | 634 | 0.290 |
Why?
| | Thoracic Surgery | 2 | 2017 | 120 | 0.270 |
Why?
| | General Surgery | 2 | 2017 | 134 | 0.260 |
Why?
| | Obesity | 2 | 2015 | 2746 | 0.260 |
Why?
| | Quality Improvement | 4 | 2017 | 963 | 0.260 |
Why?
| | Aged, 80 and over | 10 | 2017 | 6561 | 0.250 |
Why?
| | Stomach | 2 | 2015 | 103 | 0.230 |
Why?
| | Pancreatic Fistula | 1 | 2022 | 21 | 0.220 |
Why?
| | Specialties, Surgical | 1 | 2023 | 76 | 0.220 |
Why?
| | Risk Factors | 8 | 2017 | 9000 | 0.220 |
Why?
| | Anastomotic Leak | 2 | 2023 | 29 | 0.210 |
Why?
| | Humans | 30 | 2023 | 118972 | 0.210 |
Why?
| | Natural Orifice Endoscopic Surgery | 2 | 2012 | 28 | 0.200 |
Why?
| | Logistic Models | 6 | 2017 | 1901 | 0.200 |
Why?
| | Female | 25 | 2017 | 61564 | 0.200 |
Why?
| | Pancreaticoduodenectomy | 1 | 2022 | 128 | 0.200 |
Why?
| | Male | 21 | 2017 | 57801 | 0.190 |
Why?
| | Pancreatectomy | 1 | 2022 | 165 | 0.190 |
Why?
| | United States | 11 | 2023 | 12555 | 0.190 |
Why?
| | Hospital Mortality | 5 | 2017 | 814 | 0.180 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2020 | 59 | 0.180 |
Why?
| | Surgeons | 1 | 2023 | 243 | 0.180 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2016 | 610 | 0.180 |
Why?
| | Reoperation | 3 | 2016 | 557 | 0.170 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 462 | 0.170 |
Why?
| | Adult | 11 | 2017 | 31512 | 0.170 |
Why?
| | Thoracotomy | 2 | 2016 | 84 | 0.170 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1474 | 0.160 |
Why?
| | Body Mass Index | 2 | 2015 | 2092 | 0.150 |
Why?
| | Lymph Nodes | 2 | 2016 | 455 | 0.150 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 41 | 0.150 |
Why?
| | Esophageal Mucosa | 1 | 2016 | 18 | 0.140 |
Why?
| | Esophagoplasty | 1 | 2016 | 1 | 0.140 |
Why?
| | Optical Imaging | 1 | 2016 | 56 | 0.140 |
Why?
| | Specialization | 1 | 2017 | 120 | 0.140 |
Why?
| | Lymphatic Vessels | 1 | 2016 | 54 | 0.140 |
Why?
| | Conversion to Open Surgery | 1 | 2016 | 13 | 0.140 |
Why?
| | Talc | 1 | 2014 | 5 | 0.130 |
Why?
| | Pleurodesis | 1 | 2014 | 7 | 0.130 |
Why?
| | Thoracic Diseases | 1 | 2014 | 13 | 0.130 |
Why?
| | Age Factors | 4 | 2014 | 2995 | 0.130 |
Why?
| | Hepatic Artery | 1 | 2014 | 55 | 0.130 |
Why?
| | Thinness | 1 | 2015 | 91 | 0.130 |
Why?
| | Tissue Adhesions | 1 | 2014 | 31 | 0.130 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2014 | 51 | 0.130 |
Why?
| | Matched-Pair Analysis | 1 | 2014 | 39 | 0.130 |
Why?
| | Endometriosis | 1 | 2014 | 42 | 0.120 |
Why?
| | Respiration Disorders | 1 | 2014 | 66 | 0.120 |
Why?
| | Thoracic Surgical Procedures | 1 | 2014 | 64 | 0.120 |
Why?
| | Leukocyte Count | 1 | 2014 | 305 | 0.120 |
Why?
| | Standard of Care | 1 | 2014 | 63 | 0.120 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 91 | 0.120 |
Why?
| | Esophageal Achalasia | 1 | 2013 | 25 | 0.110 |
Why?
| | Postoperative Period | 1 | 2014 | 309 | 0.110 |
Why?
| | Sarcoma | 1 | 2014 | 137 | 0.110 |
Why?
| | Urinary Tract Infections | 1 | 2014 | 136 | 0.110 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 254 | 0.110 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 295 | 0.110 |
Why?
| | Gastroscopes | 1 | 2012 | 3 | 0.110 |
Why?
| | Surgical Stapling | 1 | 2012 | 9 | 0.110 |
Why?
| | Jejunum | 1 | 2012 | 30 | 0.110 |
Why?
| | Chemoradiotherapy | 1 | 2013 | 200 | 0.100 |
Why?
| | Rothmund-Thomson Syndrome | 1 | 2011 | 1 | 0.100 |
Why?
| | Surgical Wound Infection | 1 | 2014 | 251 | 0.100 |
Why?
| | Esophageal Stenosis | 1 | 2011 | 47 | 0.100 |
Why?
| | Fundoplication | 3 | 2017 | 56 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2014 | 234 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2015 | 523 | 0.100 |
Why?
| | Neoplasms | 2 | 2015 | 2179 | 0.100 |
Why?
| | Catheterization | 1 | 2011 | 163 | 0.100 |
Why?
| | Ileum | 1 | 2011 | 100 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2014 | 527 | 0.090 |
Why?
| | Rectum | 1 | 2011 | 157 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2013 | 364 | 0.090 |
Why?
| | Weight Loss | 1 | 2014 | 655 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1440 | 0.080 |
Why?
| | Biomarkers | 2 | 2014 | 3588 | 0.070 |
Why?
| | Feasibility Studies | 3 | 2016 | 749 | 0.070 |
Why?
| | Lymphatic Metastasis | 2 | 2016 | 307 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1390 | 0.070 |
Why?
| | Young Adult | 3 | 2015 | 10793 | 0.060 |
Why?
| | Chi-Square Distribution | 2 | 2016 | 525 | 0.060 |
Why?
| | Odds Ratio | 2 | 2016 | 996 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2016 | 4596 | 0.050 |
Why?
| | Lung | 1 | 2014 | 3664 | 0.050 |
Why?
| | Adolescent | 3 | 2015 | 18480 | 0.050 |
Why?
| | Survival Rate | 2 | 2016 | 1720 | 0.050 |
Why?
| | Time Factors | 3 | 2016 | 6412 | 0.050 |
Why?
| | Models, Animal | 2 | 2012 | 363 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 519 | 0.040 |
Why?
| | Comorbidity | 2 | 2014 | 1527 | 0.040 |
Why?
| | Swine | 2 | 2012 | 730 | 0.040 |
Why?
| | Incidence | 2 | 2016 | 2424 | 0.040 |
Why?
| | Gastric Fundus | 1 | 2017 | 3 | 0.040 |
Why?
| | Indocyanine Green | 1 | 2016 | 13 | 0.040 |
Why?
| | Maryland | 1 | 2016 | 36 | 0.040 |
Why?
| | Pandemics | 1 | 2023 | 1355 | 0.030 |
Why?
| | Baltimore | 1 | 2015 | 42 | 0.030 |
Why?
| | Sierra Leone | 1 | 2014 | 2 | 0.030 |
Why?
| | Breast Diseases | 1 | 2014 | 20 | 0.030 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2015 | 42 | 0.030 |
Why?
| | Esophagoscopy | 1 | 2016 | 190 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 2016 | 316 | 0.030 |
Why?
| | Uterine Diseases | 1 | 2014 | 14 | 0.030 |
Why?
| | Gastroplasty | 1 | 2014 | 26 | 0.030 |
Why?
| | Hospital Charges | 1 | 2013 | 42 | 0.030 |
Why?
| | Neoplasm, Residual | 1 | 2013 | 103 | 0.030 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2014 | 193 | 0.030 |
Why?
| | Developing Countries | 1 | 2014 | 255 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1267 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2014 | 649 | 0.030 |
Why?
| | Remission Induction | 1 | 2013 | 247 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1125 | 0.030 |
Why?
| | Malnutrition | 1 | 2013 | 66 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 2013 | 86 | 0.030 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 226 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2014 | 546 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 294 | 0.030 |
Why?
| | Pilot Projects | 1 | 2016 | 1419 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2015 | 1223 | 0.030 |
Why?
| | Recurrence | 1 | 2014 | 975 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2014 | 248 | 0.030 |
Why?
| | Hypothyroidism | 1 | 2011 | 68 | 0.020 |
Why?
| | Colonic Diseases | 1 | 2011 | 26 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 571 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 502 | 0.020 |
Why?
| | Health Status | 1 | 2016 | 726 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2014 | 545 | 0.020 |
Why?
| | Anal Canal | 1 | 2011 | 83 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 203 | 0.020 |
Why?
| | Pneumonia | 1 | 2014 | 592 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2013 | 439 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 796 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 2326 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3057 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1137 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2014 | 4552 | 0.020 |
Why?
| | Cohort Studies | 1 | 2013 | 5116 | 0.010 |
Why?
| | Heart Failure | 1 | 2013 | 1969 | 0.010 |
Why?
| | Animals | 2 | 2012 | 33381 | 0.010 |
Why?
| | Infant | 1 | 2011 | 8293 | 0.010 |
Why?
| | Child | 1 | 2014 | 19129 | 0.010 |
Why?
|
|
Mungo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|